approval · primary record
CLONIDINE
FDA · NDA · 2025-12-04
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-12-04 |
| Brand | CATAPRES-TTS-3 |
| Sponsor | LAVIPHARM |
| Route | TRANSDERMAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:19.883Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CLONIDINE:2025-12-04
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.